跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEXITAZ 100 POWDER FOR SOLUTION FOR INJECTION 100 MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
PEXITAZ 100 POWDER FOR SOLUTION FOR INJECTION 100 MG/VIAL
Approved
THERAPEUTIC
PEXITAZ 100 POWDER FOR SOLUTION FOR INJECTION 100 MG/VIAL
SUN PHARMACEUTICAL INDUSTRIES LIMITED
🇸🇬 Health Sciences Authority
Approval Date
Sep 21, 2018
Approval ID
acb2fa685d44b348
Company
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Type
Therapeutic
Approval Details
Approval Id
acb2fa685d44b348
Drug Name
PEXITAZ 100 POWDER FOR SOLUTION FOR INJECTION 100 MG/VIAL
Product Name
PEXITAZ 100 POWDER FOR SOLUTION FOR INJECTION 100 MG/VIAL
Approval Number
SIN15544P
Approval Date
2018-09-21
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01BA04
Atc Item Name
pemetrexed
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Active Ingredients
PEMETREXED DISODIUM HEPTAHYDRATE 139.79 MG EQV PEMETREXED
100.00 mg/vial
PEMETREXED DISODIUM HEPTAHYDRATE 139.79 MG EQV PEMETREXED
100 MG/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 21, 2018
Approval ID
acb2fa685d44b348
Type
Therapeutic
Back to HSA Approvals
